Skip to main content
Clinical Trials/JPRN-UMIN000053781
JPRN-UMIN000053781
Completed
N/A

Intervention study to develop a technique to detect reversible brain fatigue (electronic screen syndrome) by electronic screen using EEG measurement - Intervention study to develop a technique to detect reversible brain fatigue (electronic screen syndrome) by electronic screen using EEG measurement

Rohto Pharmaceutical Co., Ltd.0 sites33 target enrollmentMarch 5, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Rohto Pharmaceutical Co., Ltd.
Enrollment
33
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2024
End Date
November 11, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Those who have changed or newly started using health food habitually taken within the past 4 weeks 2\) Those who work night shift or day and night shift system 3\) Those who are undergoing treatment (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) at medical institutions for the treatment or prevention of disease, or those who are judged to be in need of treatment. 4\) Subjects with a history of diagnosis of serious diseases of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system nervous system, or mental disease. 5\) Those who have a history of alcohol dependence or drug dependence 6\) Those who are pregnant, breastfeeding, or wish to become pregnant while participating in the study 7\) Participated in other human studies (human studies using foods, drugs, quasi\-drugs, medical devices, etc.) within the past 4 weeks, or other studies during the scheduled period of this study plan to participate in a human trial

Outcomes

Primary Outcomes

Not specified

Similar Trials